Pertussis cases surged to more than 48,000 nationwide in 2012, exceeding the number of cases reported annually since the 1950s. While most U.S. regions have reported fewer pertussis cases in 2013 compared with 2012 (MMWR Morbid Mortal Wkly Rep. 2014;62:ND719-732), numbers are increasing again in California and the western south central United States.

Recommendations for DTaP vaccine use have not changed in more than a decade. However, Tdap vaccine recommendations have evolved to reflect measured responses to additional safety data.

With increasing reports of disease, practitioners must be clear on and implement pertussis vaccine recommendations. These vaccines include diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) for infants and children younger than 7 years of age, and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) for older children and adults.

Recommendations for DTaP use have not changed in more than a decade and include routine...

You do not currently have access to this content.